Fredun Pharmaceuticals Ltd
company logo

Fredun Pharmaceuticals Ltd

Fredun Pharma Share Price

Pharmaceuticals
Small Cap

-

0 (0%)

Invest in Fredun Pharmaceuticals Ltd
₹0 Brokerage*
Open Demat Account
*By signing up you agree to our Terms and Conditions

Fredun Pharmaceuticals Ltd Performance

-

-

-

-


-

-

-

-

-

Fredun Pharmaceuticals Ltd Fundamentals

Read More

370.18Cr

20.93

2.83

0.88

37.64

0.09%

278.45

Fredun Pharmaceuticals Ltd Financials

Fredun Pharmaceuticals Ltd Financialsright-arrow

Fredun Pharmaceuticals Ltd Shareholding Pattern

Fredun Pharmaceuticals Ltd Delivery and Volume

About Fredun Pharmaceuticals Ltd

Incorporated in 1987 as a private limited company, Fredun Pharmaceuticals (FPL) was converted into a public limited company in Mar.'94. The Company was promoted by Nariman Medhora and Daulat N Medhora. The promoters initially established D N Pharma, a proprietary firm, for the manufacture and export

Daulat N Medhora

1987

-

NameDesignation
Daulat N MedhoraWTD & Joint Managing Director
Nariman B MedhoraExecutive Director
Aspi N RaimalwalaNon-Exec. & Independent Dir.
Fredun N MedhoraManaging Director & CFO
Rohinton KangaNon-Exec. & Independent Dir.
Jinkal ShahCompany Sec. & Compli. Officer
Daisy DsouzaAdditional Director
News and Events...

Similar Stocks

What's Trending

View All
View All

Fredun Pharmaceuticals Ltd FAQs

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Fredun Pharmaceuticals Ltd shares in BlinkX.
The share price of any stock is volatile and changes during the day due to a variety of variables. Fredun Pharmaceuticals Ltd's share price is ₹787.75 as of 2024-12-02.
Fredun Pharmaceuticals Ltd's P/E ratio is 20.93 times as of 2024-12-02.
Fredun Pharmaceuticals Ltd's most recent financial reports indicate a price-to-book ratio of 2.83, showing the company's stock market valuation in relation to the value of its real assets.
Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Fredun Pharmaceuticals Ltd's market capitalization is ₹370.18 Cr as on 2024-12-02.
The current financial records of Fredun Pharmaceuticals Ltd show a 14.34% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.
According to Fredun Pharmaceuticals Ltd's most recent financial filings, the company has a total asset value of ₹256.39, which includes current and non-current assets such as inventory, cash, properties, and equipment.
The 52-week high/low price of a Fredun Pharmaceuticals Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Fredun Pharmaceuticals Ltd's 52-week high and low as of 2024-12-02 are ₹797.5 and ₹735, respectively.